A decade of innovation: perspectives from the Cell and Gene Therapy Insights Editorial Advisory Board
To celebrate the 10th anniversary of Cell & Gene Therapy Insights, members of our expert Editorial Advisory Board share their reflections on the remarkable progress of the past decade, the innovations shaping the field today, and their predictions for the future. From CRISPR-based therapies to in vivo engineering and decentralized manufacturing, their perspectives offer a snapshot of where the field stands and where it is heading next.
Institutions
- Cancer Treatment Centers of America (US)
- Regeneron (United States) (US)
- BioClinica (United States) (US)
- University Medical Center Freiburg (DE)
- TiGenix (Spain) (ES)
- 490 BioTech (United States) (US)
- BioLife Solutions (United States) (US)
- Active Biotech (Sweden) (SE)
- Canadian Blood Services (CA)
Publication Details
- Journal
- Cell and Gene Therapy Insights
- Published
- 2025-10-28
- DOI
- https://doi.org/10.18609/cgti.2025.137
- Primary Topic
- CRISPR and Genetic Engineering
- Type
- article
- Field-Weighted Citation Impact
- 0.00